Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor CytotoxicityAdrian Elter, Harald Kolmar|Frontiers in Immunology|2021Cited by 18
A Competition‐Based Strategy for the Isolation of an Anti‐Idiotypic Blocking Module and Fine‐Tuning for Conditional Activation of a Therapeutic AntibodyJan Habermann, Harald Kolmar|Biotechnology Journal|2024Cited by 4
Computational Prediction of Single-Domain Immunoglobulin Aggregation Propensities Facilitates Discovery and Humanization of Recombinant NanobodiesFelix Klaus Geyer, Harald Kolmar|Antibodies|2025Cited by 2